FR2375219B1 - - Google Patents

Info

Publication number
FR2375219B1
FR2375219B1 FR7737607A FR7737607A FR2375219B1 FR 2375219 B1 FR2375219 B1 FR 2375219B1 FR 7737607 A FR7737607 A FR 7737607A FR 7737607 A FR7737607 A FR 7737607A FR 2375219 B1 FR2375219 B1 FR 2375219B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7737607A
Other versions
FR2375219A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2375219A1 publication Critical patent/FR2375219A1/fr
Application granted granted Critical
Publication of FR2375219B1 publication Critical patent/FR2375219B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR7737607A 1976-12-22 1977-12-14 Derives de l'imidazole, leur procede de preparation et leur application Granted FR2375219A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53538/76A GB1596376A (en) 1976-12-22 1976-12-22 4,5-disubstituted imidazole-2-thiones processes for their preparation and their use as intermediates

Publications (2)

Publication Number Publication Date
FR2375219A1 FR2375219A1 (fr) 1978-07-21
FR2375219B1 true FR2375219B1 (fr) 1981-02-27

Family

ID=10468162

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7737607A Granted FR2375219A1 (fr) 1976-12-22 1977-12-14 Derives de l'imidazole, leur procede de preparation et leur application

Country Status (21)

Country Link
US (1) US4166184A (fr)
JP (1) JPS5379863A (fr)
AU (1) AU514770B2 (fr)
BE (1) BE862095A (fr)
CA (1) CA1096388A (fr)
DE (1) DE2755749A1 (fr)
DK (1) DK559877A (fr)
ES (1) ES465346A1 (fr)
FI (1) FI773592A (fr)
FR (1) FR2375219A1 (fr)
GB (1) GB1596376A (fr)
HU (1) HU177745B (fr)
IE (1) IE46493B1 (fr)
IL (1) IL53350A (fr)
LU (1) LU78725A1 (fr)
NL (1) NL7714261A (fr)
NO (1) NO774407L (fr)
PH (1) PH14357A (fr)
PT (1) PT67276B (fr)
SE (1) SE7714123L (fr)
ZA (1) ZA776538B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170872B1 (fr) * 1984-07-13 1989-08-23 Bayer Ag Procédé pour la préparation 3,7-bisacétaminoheptan-2-one
EP0428849A3 (en) * 1989-09-28 1991-07-31 Hoechst Aktiengesellschaft Retroviral protease inhibitors
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
CN109956881A (zh) * 2017-12-26 2019-07-02 上海凯赛生物技术研发中心有限公司 一种苯甲酰戊二胺及其制备和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2585388A (en) * 1948-11-17 1952-02-12 Lilly Co Eli Preparation of 2-mercaptoimidazoles
GB1054708A (fr) * 1964-10-02

Also Published As

Publication number Publication date
LU78725A1 (fr) 1978-04-17
GB1596376A (en) 1981-08-26
FR2375219A1 (fr) 1978-07-21
IE46493B1 (en) 1983-06-29
BE862095A (fr) 1978-06-21
PT67276B (en) 1979-04-18
IL53350A0 (en) 1978-01-31
ZA776538B (en) 1978-08-30
ES465346A1 (es) 1978-09-16
FI773592A (fi) 1978-06-23
US4166184A (en) 1979-08-28
PT67276A (en) 1977-12-01
JPS5379863A (en) 1978-07-14
HU177745B (en) 1981-12-28
CA1096388A (fr) 1981-02-24
IL53350A (en) 1981-10-30
SE7714123L (sv) 1978-06-23
DK559877A (da) 1978-06-23
DE2755749A1 (de) 1978-06-29
AU514770B2 (en) 1981-02-26
NO774407L (no) 1978-06-23
IE46493L (en) 1978-06-22
AU3157277A (en) 1979-06-21
NL7714261A (nl) 1978-06-26
PH14357A (en) 1981-06-03

Similar Documents

Publication Publication Date Title
FR2370306B3 (fr)
FR2371521B2 (fr)
FR2375219B1 (fr)
JPS5722111Y2 (fr)
JPS5728703Y2 (fr)
JPS5347149U (fr)
JPS5733292Y2 (fr)
JPS5548381B2 (fr)
JPS5298250U (fr)
CS177780B1 (fr)
CS176994B1 (fr)
CS175506B1 (fr)
JPS5312594U (fr)
JPS5293219U (fr)
CS178376B1 (fr)
CS178386B1 (fr)
BR5600715U (fr)
CH602246A5 (fr)
CH606961A5 (fr)
CH599612B5 (fr)
CH599714A5 (fr)
CH600826A5 (fr)
CH601667A5 (fr)
CH598954A5 (fr)
CH602390A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse